Sensitivity and specificity of urinary hyaluronic acid and hyaluronidase in detection of bladder transitional cell carcinoma

Urology Journal

Volumn 11, Issue 1, 2014, Pages 1232-1237

  Jamshidian, Hassan ^a   Hashemi, Mohsen ^a   Nowroozi, Mohammad Reza ^a   Ayati, Mohsen ^a   Bonyadi, Mahdieh ^a   Tousi, Vahid Najjaran ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

diagnostic errors; Hyaluronic acid; Neoplasm grading; Transitional cell; Urinary bladder neoplasms

Indexed keywords

HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER TUMOR; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; URINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84896480635     PISSN: 17351308     EISSN: 1735546X     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Simpson MA, Lokeshwar VB. Hyaluronan and hyaluronidase in genitourinary tumors. Front Biosci. 2008;13:5664-80.
2. Johansson SL, Cohen SM. Epidemiology and etiology of bladder cancer. Semin Surg Oncol. 1997;13:291-8.
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin. 2009;59:225-49.
4. Herr HW. Natural history of superficial bladder tumors: 10- to 20- year follow-up of treated patients. World J Urol. 1997;15:84-8.
5. Kriegmair M, Baumgartner R, Knuchel R, Stepp H, Hofstadter F, Hofstetter A. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol. 1996;155:105-9.
6. Mufti GR, Singh M. Value of random mucosal biopsies in the management of superficial bladder cancer. Eur Urol. 1992;22:288-93.
7. Meredith F. Campbell PCW, Alan B. Retik, E. Darracott Vaughan. Campbell's Urology. 9th edition ed 2007. Volume 3, page 2465.
8. Halling KC, King W, Sokolova IA et al. A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine. J Urol. 2002;167:2001-6.
9. Nussbaum RL, McInnes RR, Willard HF, Thompson MW. Thompson & Thompson genetics in medicine. 6th ed Philadelphia: Saunders; 2001. p. 234.
10. Burchardt M, Burchardt T, Shabsigh A, De La Taille A, Benson MC, Sawczuk I. Current concepts in biomarker technology for bladder cancers. Clin Chem. 2000;46:595-605.
11. Fraser JR, Laurent TC, Laurent UB-Hyaluronan: its nature, distribution, functions and turnover. J Intern Med. 1997;242:27-33.
12. West DC, Hampson IN, Arnold F, Kumar S-Angiogenesis induced by degradation products of hyaluronic acid. Science. 1985;228:1324-6.
13. De Klerk DP, Lee DV, Human HJ.Glycosaminoglycans of human prostatic cancer. J Urol. 1984;131:1008-12.
14. Stern R, Jedrzejas MJ-Hyaluronidases: their genomics, structures, and mechanisms of action. Chem Rev. 2006;106:818-39.
15. Lokeshwar VB, Cerwinka WH, Isoyama T, Lokeshwar BL. HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor. Cancer Res. 2005;65:7782-9.
16. Lokeshwar VB, Cerwinka WH, Lokeshwar BL. HYAL1 hyaluronidase: a molecular determinant of bladder tumor growth and invasion. Cancer Res. 2005;65:2243-50.
17. Lokeshwar VB, Obek C, Pham HT, et al. Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade. J Urol. 2000;163:348-56.
18. Lokeshwar VB, Obek C, Soloway MS, Block NL. Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer. Cancer Res. 1997;57:773-7.